Home
About
FAQ
History (11)
A molecular biomarker for prediction of clinical outcome in children with ASD, constipation, and intestinal inflammation.
Exposed versus buried intramedullary implants for pediatric forearm fractures: a comparison of complications.
Nonobstructive Acute Renal Failure with a Large Solitary Fibroid.
Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography.
Peritoneal carcinomatosis: what can we do about it?
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Peritoneal carcinomatosis: what can we do about it?
Shen P, Levine EA, Loggie BW. Peritoneal carcinomatosis: what can we do about it? J Clin Oncol. 2004 Jan 01; 22(1):202; author reply 203.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Carcinoma
Combined Modality Therapy
Humans
Hyperthermia, Induced
Infusions, Parenteral
Patient Care Planning
Patient Selection
Peritoneal Neoplasms
authors with profiles
Perry Shen MD
Edward A. Levine MD